Astacin metalloproteases in human-parasitic nematodes
- PMID: 39448190
- PMCID: PMC12460076
- DOI: 10.1016/bs.apar.2024.03.001
Astacin metalloproteases in human-parasitic nematodes
Abstract
Parasitic nematodes infect over 2 billion individuals worldwide, primarily in low-resource areas, and are responsible for several chronic and potentially deadly diseases. Throughout their life cycle, these parasites are thought to use astacin metalloproteases, a subfamily of zinc-containing metalloendopeptidases, for processes such as skin penetration, molting, and tissue migration. Here, we review the known functions of astacins in human-infective, soil-transmitted parasitic nematodes - including the hookworms Necator americanus and Ancylostoma duodenale, the threadworm Strongyloides stercoralis, the giant roundworm Ascaris lumbricoides, and the whipworm Trichuris trichiura - as well as the human-infective, vector-borne filarial nematodes Wuchereria bancrofti, Onchocerca volvulus, and Brugia malayi. We also review astacin function in parasitic nematodes that infect other mammalian hosts and discuss the potential of astacins as anthelmintic drug targets. Finally, we highlight the molecular and genetic tools that are now available for further exploration of astacin function and discuss how a better understanding of astacin function in human-parasitic nematodes could lead to new avenues for nematode control and drug therapies.
Keywords: Astacins; Filarial nematodes; Helminths; Hookworms; Human-parasitic nematodes; Molting; Neglected tropical diseases; Skin penetration; Strongyloides; Zinc metalloproteases.
Copyright © 2024. Published by Elsevier Ltd.
Figures
References
-
- Abadie SH, 1963. The life cycle of Strongyloides ratti. J Parasitol 49, 241–248. - PubMed
-
- Abraham D, Graham-Brown J, Carter D, Gray SA, Hess JA, Makepeace BL, and Lustigman S, 2021. Development of a recombinant vaccine against human onchocerciasis. Expert Rev Vaccines 20, 1459–1470. - PubMed
-
- Adegnika AA, de Vries SG, Zinsou FJ, Honkepehedji YJ, Dejon Agobe JC, Vodonou KG, Bikangui R, Bouyoukou Hounkpatin A, Bache EB, Massinga Loembe M, et al. , 2021. Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial. Lancet Infect Dis 21, 275–285. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
